Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CHM has updated his blog. Claims bombshell for May 30

<On May 30, I post the Stipulated Final Judgment wherein Leckrone conned a Federal Judge into giving him my patents. (A public document)>

What the above is telling me is that Leckrone owns the other half of the MMP, not Moore. And the agreement is sipulated, so I guess Chuck's battle may not be about ownership, but about Leckrone not living up to the financial agreement Moore say they had.

If the above is true, it may be necessary to revise the commercialization agreement because the parties to the agreement are no longer the same? Could someone post a link to that agreement? TIA

Opty

Share
New Message
Please login to post a reply